美国深奥测试市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

Publication Month : Dec 2023

  • Report Code : TIPRE00031812
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 128
Inquire Before Buy

PRICING

$3550

$2840

美国深奥测试市场规模预计将从2022年的103.8285亿美元增长到2030年的312.7434亿美元;预计 2022 年至 2030 年市场复合年增长率为 14.8%。
市场洞察和分析师观点:
深奥测试包括测试稀有物质或分子的样品,并且不作为常规测试的一部分进行。这一部分的诊断需要高技能的专业人员以及先进和复杂的设备。它们主要在专业实验室中进行,其中样本由医生或医院转介(住院测试)或由患者自己转介(门诊测试)。目前,其中一些测试基于放射免疫分析技术,该技术既昂贵又耗时。过去几年,COVID-19 大流行为深奥测试市场提供了显着的增长前景。 RT-PCR 检测是一种常用方法,用于对从疑似 COVID-19 患者收集的上呼吸道和下呼吸道样本(例如鼻咽或口咽拭子和痰)中提取的 SARS-CoV-2 RNA 进行定性鉴定。
增长动力:
慢性病患病率上升推动美国深奥检测市场
根据美国心脏协会 2021 年发布的一项研究,美国有超过 1.3 亿成年人可能患有某些疾病美国癌症协会于 2022 年 1 月发布的《2022 年癌症事实与数据》指出,美国报告 2022 年将有近 190 万例新癌症诊断和 609,360 例与癌症相关的死亡。癌症发病率上升,负担沉重其他慢性疾病的发生需要精确的诊断和治疗。据美国甲状腺协会估计,超过 12% 的美国人在一生中预计会患上甲状腺疾病。由于食用不健康食品和久坐的生活方式而导致荷尔蒙失调的发病率激增,导致北美地区内分泌学检查的普及。内分泌测试用于诊断激素紊乱,如垂体、甲状腺、肾上腺骨、类癌和神经内分泌以及甲状旁腺肿瘤。
深奥的测试可以分析常规临床实验室测试中不包括的稀有分子或物质。这些测试通常在遗传学、免疫学、微生物学、内分泌学、分子诊断、血清学、毒理学和肿瘤学等医学专业中进行。分子遗传学或分子诊断原理通常应用于确定疾病的预后。例如,对骨髓活检样本进行的分子诊断测试可包括但不限于BCR/ABL、NPM1、FLT3、CEBPA和JAK2。因此,慢性病的日益流行推动了诊断中对深奥测试的需求,这有利于美国深奥测试市场。
战略见解
报告细分和范围:
“美国深奥测试市场”已细分基于类型、技术和最终用户。根据类型,市场分为传染病检测、内分泌检测、肿瘤检测、毒理学检测、免疫学检测、神经学检测等。从技术上看,美国深奥检测市场分为化学发光免疫分析、酶联免疫吸附分析、质谱分析、实时PCR、DNA测序、流式细胞术等。就最终用户而言,市场分为医院和实验室以及独立和参考实验室。
细分分析:
美国深奥检测市场按类型分为传染病检测、内分泌检测、肿瘤学测试、毒理学测试、免疫学测试、神经学测试等。肿瘤检测领域在 2022 年占据最大的市场份额。传染病检测领域预计在 2022 年至 2030 年期间复合年增长率最高。传染病有多种传播方式;因此,及时诊断和治疗是限制其传播的关键。实验室测试是确认感染诊断的唯一方法。一些廉价且方便的血液测试可以诊断流感、莱姆病、EB病毒感染等。通过基因检测可以轻松识别致病细菌和病毒。实验室进行的主要测试类型包括培养、显微镜检查、免疫学测试、基于核酸的鉴定方法和基于非核酸的鉴定方法。
聚合酶链式反应 (PCR) 是用于鉴定传染病的深奥测试的一个例子。该技术用于从引起感染的微生物中复制特定基因,从而使它们的识别变得容易。 PCR 检测是 COVID-19 检测的“黄金标准”。根据《我们的世界》的数据统计,截至 2022 年 6 月,美国进行了 9.0944 亿次 RT-PCR 检测。
美国深奥检测市场,按类型 - 2022 年和 2030 年
基于技术,美国深奥检测市场是分为化学发光免疫分析、酶联免疫吸附分析、质谱分析、实时PCR、DNA测序、流式细胞术等。化学发光免疫分析领域在 2022 年占据最大的市场份额。酶联免疫吸附分析领域预计在 2022 年至 2030 年期间复合年增长率最高,达到 18.7%。免疫测定利用生物化学原理来检测和测量分析物,分析物可以是大蛋白质、抗体(因感染而产生)或小分子。这些高度适应性的测定可用于确定各种类型的分析物,具体取决于用户的需求。化学发光免疫分析是标准酶免疫分析(EIA)的一种,代表生化技术在免疫学中的应用。
直接化学发光方法使用发光团标记,而间接方法使用酶标记。化学发光分析方法的主要优点包括应用范围广、信号强度高、无干扰发射(特异性高)、分析信号快速采集、试剂及其缀合物稳定性高、试剂消耗低、随机获取、减少孵育时间时间,并与免疫学检测协议完全兼容。
根据最终用户,美国深奥检测市场分为医院和实验室以及独立和参考实验室。 2022 年,医院和实验室领域占据了更大的市场份额。预计 2022 年至 2030 年复合年增长率将达到 15.2%。几乎所有医院都设有实验室,其运作规模与其服务的人口成正比。医院实验室需要在有限的时间内处理数百个样本。这包括紧急情况下所需并大量进行的所有测试,例如心脏生物标志物(肌钙蛋白)测试,其中需要快速获得结果以进行有效的患者护理。医院实验室的工作量可以根据测试类型进行划分。这些设施的工作人员均接受过特定专业的培训,主要包括血液学、微生物学、化学和血库。其他单位可以使用电子显微镜和免疫组织化学进行专门的测试,重点是外科病理学和细胞学(分析细胞和组织结构)。位于美国罗彻斯特的梅奥诊所是美国诊断糖尿病和内分泌学的最佳机构之一。该诊所对内分泌学进行深奥测试。
国家分析:
美国的深奥测试市场主要是由慢性病患病率上升以及人们对早期发现医疗状况的意识不断增强所推动的。深奥测试通常用于分析常规测试中未包含的稀有和独特物质。为了进行这些测试,临床实验室需要相关专业的专业知识。因此,大型商业实验室将这些复杂的测试外包给参考和深奥的测试实验室。在美国进行深奥测试的一些实验室包括 Quest Diagnostics Incorporated、Mayo Medical Laboratories、ARUP Laboratories、Myriad Genetics、Genomic Health、Foundation Medicine 和 Laboratory Corporation of America。国内有能力进行这些专门测试的实验室数量正在进一步增加。
根据内分泌学会 2022 年 1 月发表的一篇文章,性腺功能减退症是男性人群中的常见病症,患病率较高老年男性、肥胖男性和患有 2 型糖尿病的男性。据估计,45 岁以上男性中 35% 以及患有 2 型糖尿病或肥胖症的男性中 30-50% 患有性腺功能减退症。此外,根据美国人口普查局的估计,65岁及以上男性性腺功能减退症的发病率从2000年的约3500万增至2020年的约5500万。此外,预计到2050年将增至约8700万。这种疾病的患病率激增是由于美国老年人口的增加。
美国对深奥检测的需求激增也归因于肝硬化病例的增加。根据 Statista 的数据,2020 年美国有 51,642 名成年人死于肝病。慢性肝病/肝硬化是 2020 年美国第 12 大死亡原因;酒精性肝硬化发病率的增加是这种疾病的主要危险因素。
预计合作和伙伴关系也将在未来几年推动美国深奥检测市场的增长。根据美国国立卫生研究院 (NIH) 2021 年 10 月新闻稿——NIH、美国食品和药物管理局 (FDA)、10 家制药公司和 5 家非营利组织联手加速基因领域相关发展为 3000 万患有罕见疾病的美国人提供治疗支持。罕见病有近7000种,目前只有2种遗传性疾病有FDA批准的基因疗法。最近成立的定制基因治疗联盟 (BGTC) 是 NIH 加速药物合作伙伴 (AMP) 计划的一部分,也是 NIH 基金会领导的一个项目,旨在加强和简化基因治疗的开发流程,以支持未满足的医疗需求患有各种罕见疾病的个体。
因此,性腺功能减退症、肝硬化和其他类似疾病的病例不断增加,正在推动美国深奥检测市场的增长。
行业发展和未来机遇:
美国深奥测试市场的主要参与者采取的各种举措如下:
2022 年 3 月,沃特世公司推出了 Xevo TQ Absolute 系统,这是一款高灵敏度、紧凑的台式串联质谱仪。这款最新的质谱仪可量化负电离化合物,其灵敏度比其前身高出 15 倍,尺寸缩小 45%。此外,它消耗的电力和天然气最多可减少 50%。 2021 年 2 月,Quest Diagnostics 与 Grail 合作进行 Galleri 多种癌症血液检测。 Quest Diagnostics 计划使用 Galleri 多癌早期检测血液检测提供静脉放血服务。 2021 年 1 月,OPKO Health (OPK) 旗下公司 BioReference Laboratories, Inc. 推出了 Scarlet Health。它是一个完全集成的家用数字平台,可提供按需诊断服务。与日常使用的设备类似,Scarlet 的设计宗旨是提供易用性、普遍性和便利性。当需要放血和其他标本采集服务时,该平台为传统患者服务中心或其他抽取地点提供了创新、灵活、移动的替代方案。2021 年 9 月,LabCorp 从 Myriad Genetics 的自身免疫业务部门收购了运营资产和知识产权 (IP) ,包括 Vectra 类风湿性关节炎 (RA) 检测。通过此次收购,LabCorp 预计将巩固其在风湿病学领域的科学领导地位。 2020 年,Quest Diagnostics 收购了纪念赫尔曼健康系统 (Memorial Hermann Health System) 的外展实验室服务业务 Blueprint Genetics。通过这项多年期收购协议,Quest 计划为 Memorial Hermann 的所有 21 个医院实验室提供专业的实验室管理服务,这些实验室提供现场快速反应测试。 Quest 还计划成为纪念赫尔曼健康计划的唯一实验室服务提供商。2019 年,Sonic Healthcare 收购了 Aurora Diagnostics,以扩大其在美国解剖病理学专业的影响力。竞争格局和主要公司:
Georgia Esoteric & Molecular Laboratory LLC、Laboratory Corp of America Holdings、Quest Diagnostics Inc、National Medical Services Inc、OPKO Health Inc、ARUP Laboratories Inc、bioMONTR Labs、Athena Esoterix LLC、Stanford Hospital & Clinics 和 Foundation Medicine Inc 都是该领域的知名公司。美国深奥的测试市场。这些公司专注于引进新技术、升级现有产品以及扩大地理覆盖范围,以满足全球不断增长的消费者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the US Esoteric Testing Market?

The US esoteric testing market is analyzed on type, technology, and end user. Based on type, the market is segmented into infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. In terms of technology, the US esoteric testing market is divided into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, DNA sequencing, flow cytometry, and others. In terms of end user, the market is categorized into hospitals and laboratories, and independent and reference laboratories. infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. The oncology testing by type segment held the largest market share in 2022. The infectious disease testing segment is anticipated to register the highest CAGR during 2022–2030.

Who are the major players in the US Esoteric Testing Market?

The US esoteric testing market majorly consists of the players such as Georgia Esoteric & Molecular Laboratory LLC, Laboratory Corp of America Holdings, Quest Diagnostics Inc, National Medical Services Inc, OPKO Health Inc, ARUP Laboratories Inc, bioMONTR Labs, Athena Esoterix LLC, Stanford Hospital & Clinics, and Foundation Medicine Inc.

What are the driving factors for the US Esoteric Testing Market?

The growth of the market is attributed to rising prevalence of chronic diseases and growing awareness regarding early detection of medical conditions are the key driving factors behind the market development. However, the lack of skilled personnel and high cost of procedure are hampering the market growth.

The List of Companies - US Esoteric Testing Market

  1. Georgia Esoteric & Molecular Laboratory LLC
  2. Laboratory Corp of America Holdings
  3. Quest Diagnostics Inc
  4. National Medical Services Inc
  5. OPKO Health Inc
  6. ARUP Laboratories Inc
  7. bioMONTR Labs
  8. Athena Esoterix LLC
  9. Stanford Hospital & Clinics
  10. Foundation Medicine Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports